Alerts will be sent to your verified email
Verify EmailNATCOPHARM
|
Natco Pharma
|
Eris Lifesciences
|
Wockhardt
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Number of ANDA's Filed in USA
|
51.0 . | n/a | n/a |
|
Number of ANDA's Approved By USFDA
|
41.0 . | n/a | n/a |
|
Domestic Sales Growth - YoY
|
31.2 % | 6.1 % | 10.6 % |
|
US DMF Filings
|
58.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
9.1 % | 0.0 | 4.4 % |
|
Financials
|
|||
|
5 yr Average ROE
|
15.58 % | 17.74 % | 4.06 % |
|
5yr average Equity Multiplier
|
1.17 | 1.76 | 2.02 |
|
5yr Average Asset Turnover Ratio
|
0.48 | 0.51 | 0.39 |
|
5yr Avg Net Profit Margin
|
26.79 % | 22.76 % | -4.28 % |
|
Price to Book
|
1.96 | 5.86 | 4.27 |
|
P/E
|
10.88 | 41.96 | 885.43 |
|
5yr Avg Cash Conversion Cycle
|
4.27 Days | -54.68 Days | -94.15 Days |
|
Inventory Days
|
91.91 Days | 27.48 Days | 61.29 Days |
|
Days Receivable
|
93.3 Days | 54.07 Days | 60.36 Days |
|
Days Payable
|
134.54 Days | 148.48 Days | 251.45 Days |
|
5yr Average Interest Coverage Ratio
|
60.49 | 66.44 | -0.43 |
|
5yr Avg ROCE
|
19.09 % | 18.34 % | -0.28 % |
|
5yr Avg Operating Profit Margin
|
34.0 % | 34.43 % | 5.03 % |
|
5 yr average Debt to Equity
|
0.06 | 0.46 | 0.56 |
|
5yr CAGR Net Profit
|
33.73 % | -0.19 % | n/a |
|
5yr Average Return on Assets
|
13.46 % | 12.4 % | -1.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
49.48 % | 54.85 % | 49.08 % |
|
Share Pledged by Promoters
|
0.0 | 16.92 % | 18.04 % |
|
Change in Promoter Holding (3 Yrs)
|
0.66 % | 2.15 % | -11.28 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-6.58 % | 8.62 % | 7.72 % |
|
Natco Pharma
|
Eris Lifesciences
|
Wockhardt
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
Therapeutic Area Wise Break-Up - Domestic
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|